Moderna SG&A Expense (Quarterly) Analysis

Moderna Inc (MRNA)

106.18 -2.67 (-2.45%) USD | NASDAQ | Apr 25, 16:00

106.21 +0.03 (+0.03%) After-Hours: 06:33

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	470.00M
September 30, 2023	442.00M
June 30, 2023	332.00M
March 31, 2023	305.00M
December 31, 2022	375.00M
September 30, 2022	278.00M
June 30, 2022	211.00M
March 31, 2022	268.00M
December 31, 2021	201.00M
September 30, 2021	168.00M
June 30, 2021	121.00M
March 31, 2021	77.00M
December 31, 2020	79.00M

Date	Value
September 30, 2020	48.00M
June 30, 2020	37.00M
March 31, 2020	24.00M
December 31, 2019	26.09M
September 30, 2019	28.17M
June 30, 2019	28.49M
March 31, 2019	27.25M
December 31, 2018	38.02M
September 30, 2018	18.52M
June 30, 2018	21.39M
March 31, 2018	16.32M
December 31, 2017	15.90M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

24.00M

Minimum

Mar 2020

470.00M

Maximum

Dec 2023

185.20M

Average

168.00M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks